Pulse Biosciences (PLSE) to Release Quarterly Earnings on Thursday

Pulse Biosciences (NASDAQ:PLSE) is scheduled to be issuing its quarterly earnings data after the market closes on Thursday, March 28th. Parties interested in registering for the company’s conference call can do so using this link.

Pulse Biosciences Stock Down 4.7 %

NASDAQ:PLSE opened at $8.54 on Tuesday. The firm has a market capitalization of $470.39 million, a PE ratio of -9.28 and a beta of 1.69. Pulse Biosciences has a 12-month low of $2.36 and a 12-month high of $13.62. The firm has a 50-day moving average price of $9.25 and a 200 day moving average price of $7.68.

Institutional Trading of Pulse Biosciences

Several large investors have recently added to or reduced their stakes in the company. LM Advisors LLC bought a new stake in shares of Pulse Biosciences during the fourth quarter valued at approximately $30,000. BNP Paribas Arbitrage SNC grew its stake in shares of Pulse Biosciences by 713.8% during the second quarter. BNP Paribas Arbitrage SNC now owns 4,199 shares of the company’s stock valued at $30,000 after purchasing an additional 3,683 shares during the last quarter. Citigroup Inc. bought a new stake in shares of Pulse Biosciences during the second quarter valued at approximately $35,000. California State Teachers Retirement System bought a new stake in shares of Pulse Biosciences during the second quarter valued at approximately $39,000. Finally, Tower Research Capital LLC TRC bought a new stake in shares of Pulse Biosciences during the second quarter valued at approximately $68,000. 6.62% of the stock is owned by institutional investors.

Pulse Biosciences Company Profile

Pulse Biosciences, Inc operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology.